DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
| You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
| To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online groups, photo galleries and blogs
@GDATF
This is the official Twitter account for the Graves’ Disease & Thyroid Foundation (GDATF). The Graves’ Disease & Thyroid Foundation provides educational and support services for patients with Graves’ disease, thyroid eye disease & related disorders.
myBinderRelated Content
-
People & PlacesUniversity of Louisville PhysiciansUniversity of Louisville Physicians is t...
-
Videos & VisualsFocus On Eye Health Expert Series: Thyroid Eye Disease (TED)https://www.youtube.com/watch?v=-g2UPKrQ...
-
People & PlacesKyle Godfrey, MDKyle J. Godfrey, M.D. is an Assistant Pr...
-
Community CenterAngels Announcer Victor Rojas Stays Strong for His Wife in Her Health BattleShe braces herself for the worst. Stayin...
-
People & PlacesCesar A. Briceno, MDCesar A. Briceno is an Associate Profess...
-
Evidence & EducationChanges in Cardiac Function and Structure in Newly Diagnosed Graves’ Disease. A Conventional and 2D-Speckle Tr...Overproduction of thyroid hormones leads...
-
Evidence & EducationManagement of Endocrine Disease: Rituximab Therapy for Graves’ Orbitopathy – Lessons From Randomized Con...Rituximab (RTX) use in open-label series...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.